Ongoing Chest Pain With a Negative Early Troponin
A 58-year-old man with hypertension and a 30-pack-year smoking history presents to the emergency department with 45 minutes of substernal pressure radiating to the left arm, associated with diaphoresis and nausea. His pain is 7/10 and persists after aspirin 300 mg chewed. Blood pressure is 150/90 mmHg, heart rate 96 beats/min, respiratory rate 18 breaths/min, and oxygen saturation 97% on room air. Cardiac auscultation reveals no murmur, and the lungs are clear. A 12-lead ECG shows 1 mm horizontal ST depression in V4–V6 and T-wave inversion in leads I and aVL. The first high-sensitivity troponin is below the limit of detection at 1 hour. Chest radiograph is normal, eGFR is 70 mL/min/1.73 m², and there is no bleeding history. The ED physician must decide on disposition, initial antithrombotic therapy, and whether urgent angiography is needed.
1. What immediate disposition and risk stratification are appropriate, and why is a single negative troponin not reassuring?
Read the worked answer
This patient has ongoing ischemic pain, dynamic ST-T changes, and multiple risk factors, so he is high risk even with an undetectable 1-hour troponin. A single early troponin cannot exclude NSTEMI; high-sensitivity assays require serial sampling at 0/1 h or 0/3 h. His HEART score is at least 6 (history, ECG, age, risk factors; troponin currently 0), which predicts a high 6-week major adverse cardiac event rate. He should be admitted to a monitored bed, placed on continuous telemetry, and evaluated urgently by cardiology. Do not discharge him for outpatient stress testing. Obtain repeat troponin, creatinine, CBC, and coagulation studies; continue aspirin. If pain persists or ECG changes evolve, treat as high-risk NSTE-ACS and plan early invasive evaluation rather than waiting for the second troponin. The reasoning is that clinical instability and dynamic ECG changes outweigh a single negative biomarker.
2. Which antiplatelet and anticoagulant therapy should be started now, and what is the role of morphine?
Read the worked answer
In addition to aspirin, add a P2Y12 inhibitor-ticagrelor 180 mg loading dose or clopidogrel 600 mg if ticagrelor is unavailable or contraindicated-because an invasive strategy is likely. Start anticoagulation with unfractionated heparin (for example, 60 U/kg bolus, maximum 4,000 U, with infusion) or enoxaparin 1 mg/kg subcutaneously every 12 h if renal function permits; avoid both simultaneously. Do not give fibrinolytics for NSTE-ACS. Morphine should be reserved for refractory ischemic pain or severe pulmonary edema, not routine use. It can cause hypotension, reduce preload, and delay absorption of oral antiplatelet agents; it may also mask worsening ischemia. If used, give small IV doses with monitoring and reassess frequently. The key judgement is to treat suspected NSTE-ACS with dual antiplatelet therapy and parenteral anticoagulation while arranging early invasive risk assessment, rather than relying on analgesia alone.
3. The 3-hour troponin returns at 45 ng/L (upper reference limit 14 ng/L). How does this change management?
Read the worked answer
A rise above the 99th percentile with a changing pattern confirms myocardial injury and, in this clinical setting, NSTEMI. He now has high-risk NSTE-ACS: ongoing pain, dynamic ECG changes, and a positive troponin. He needs admission to a coronary care or monitored unit, continued dual antiplatelet therapy and anticoagulation, and an early invasive strategy. Current guidelines favor angiography within 24 hours for high-risk NSTE-ACS; if he develops refractory pain, hemodynamic instability, acute heart failure, or malignant arrhythmia, proceed within 2 hours. Fibrinolysis is not indicated. Calculate the GRACE score and review bleeding risk before catheterization. Check renal function before contrast and continue statin therapy. The change from a negative to a positive troponin is not just a lab update-it reclassifies him from possible unstable angina to NSTEMI and mandates invasive risk stratification.